Effectiveness of ustekinumab dose escalation in Crohn's disease patients with insufficient response to standard-dose subcutaneous maintenance therapy
Background Ustekinumab is effective in Crohn's disease. However, a substantial proportion of patients will not respond or lose response to ustekinumab. The current evidence to support the effectiveness of dose-optimisation for ustekinumab nonresponse is limited.Aim To assess the effectiveness o...
Elmentve itt :
| Szerzők: | |
|---|---|
| Dokumentumtípus: | Cikk |
| Megjelent: |
2020
|
| Sorozat: | ALIMENTARY PHARMACOLOGY & THERAPEUTICS
52 No. 1 |
| doi: | 10.1111/apt.15784 |
| mtmt: | 31507883 |
| Online Access: | http://publicatio.bibl.u-szeged.hu/19611 |